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Eighteen years after an opinion piece entitled ‘Lessons from the 1992 
measles epidemic in South Africa’ was published in the SAMJ1 we 
now need to revisit the same message. This follows on the recent 
2009/2011 outbreak, which has involved over 18 000 recognised 
cases and, presumably, several hundred deaths and many more 
children who will suffer permanent disabilities. This comes close 
to the 22 000 cases of the 1992 outbreak. The message remains the 
same. Why is this infectious disease, which is so easily prevented 
by a highly effective, safe and relatively inexpensive vaccine, still 
such a major cause of morbidity and mortality? Simply put, there 
are two related reasons. Firstly, measles ranks as one of the most 
contagious of all organisms, with a basic reproductive rate (a measure 
of its transmissibility) exceeding that of any other human pathogen.2 
Secondly, because of this, control of measles demands exceptionally 
high vaccination coverage, of the order of 95%, if transmission is to be 
interrupted and outbreaks prevented.3,4 The difficulty in maintaining 
such a high coverage in all districts of a country is a global problem, 
and 2010/2011 has seen outbreaks in many parts of the developed 
world, with 10 - 20-fold increases over previous years in measles cases 
in Europe and even a 10-fold increase in imported cases in the USA.5,6 
Initially South Africa had a reasonably good record with measles. It 
was one of the first countries in Africa to introduce measles vaccine 
(in 1975) and to adopt a two-dose schedule (at 9 and 18 months, in 
1995).7 By 2003 it looked as if South Africa was well on the way to 
measles elimination. Between 1998 and 2003 an average of only 33 
laboratory-confirmed measles cases per year were reported, with no 
deaths.8 Unfortunately, however, in 2003 the first of the post-1992 
epidemics broke out, albeit relatively smaller than 1992, with 1 676 
cases reported by the National Institute for Communicable Diseases.9 
Four years later the 2009/2011 epidemic rivals that of 1992, with 
18 434 laboratory-confirmed cases as at 19 May 2011.10
With the end of the current epidemic the great majority of the 
population has now been immunised, either by the vaccine or 
by wild-type virus. There is therefore now a breathing space that 
affords public health planners an opportunity to examine this last 
epidemic in detail in order to plan on preventing future epidemics. 
These will certainly occur within a few years as a fresh cohort of 
susceptibles enters the population, unless the deficiencies preceding 
2009 are not urgently addressed. To plan ahead rationally, we need to 
recognise that South Africa currently cannot claim to be in a measles 
elimination phase. More realistically we are rather in an outbreak 
prevention phase, and short-term planning must be focused on 
measures urgently needed to prevent future epidemics. However, 
the temptation to respond by rushing into making changes to the 
current programme needs to be resisted unless there is compelling 
evidence to do so. The planning needs to a follow a rational and 
systematic sequence. May I suggest the acronym ‘MAMI’, to denote 
measurement, analysis, motivation and implementation?
Measurement – and in-depth investigation and study of the 2009 
epidemic – must be undertaken in the first instance. 
Analysis. Examination of these data would then define the 
shortcomings and indicate the research questions that need to be 
addressed. These could include acquiring reliable vaccine coverage 
data, possibly augmented by serosurveillance studies, and vaccine 
responses in South African children at different ages and HIV 
status. Additional tools such as modelling could also assist in 
forward planning, for example to assess the value of supplementary 
immunisation programmes. 
Motivation. The next step would be to convince decision makers 
of the cost-effectiveness of acting proactively rather than reactively. 
In addition to health planners, many layers of society from health 
care professionals to parents and caregivers need to be energised 
to avoid a repetition of 2009, particularly now in an inter-epidemic 
period when there is a danger that lack of disease visibility will be 
likely to engender complacency. 
Implementation. What emerges from a thorough analysis and 
in-depth study of measles in South Africa must now be rationally 
implemented. Planning must include the possibility that we will not 
be successful in circumventing future outbreaks, and an outbreak 
preparedness protocol, not unlike that set up for pandemic influenza, 
needs to be constructed for measles. Most importantly, sensitive 
clinical surveillance for early diagnosis of an impending outbreak is 
crucial.
It is of interest that as far back as 2002 a meeting of the World 
Health Organization International Task Force for Disease Eradication 
deemed measles to be technically feasible for eradication and stated 
that ultimately it should be a desirable goal.11 South Africa, which was 
a pioneer on the continent in measles vaccination, should similarly be 
in a position to be the forerunner in Africa for measles elimination.
The opinions expressed are the personal opinions of the author 
and do not necessarily reflect the views of the Institution or any other 
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